Gene-therapy program for hereditary kidney disease
Animal validation data have been obtained, and candidate-vector assessment is continuing.
Specific targets, vector sequences and detailed mechanisms are undisclosed.VALIDATED07RESEARCH PROGRESS
Evidence informs every R&D decision
Research findings will be disclosed progressively in line with intellectual property and partnership considerations.
Antibody program for immune-mediated kidney disease
Antibody candidate discovery and screening continue to advance.
Specific targets, epitopes and candidate mechanisms are undisclosed.DISCOVERYAI model for antibody design
Supports antibody candidate generation, experimental screening and iterative optimization.
IN DEVELOPMENTAI model for oligonucleotide design
Supports oligonucleotide candidate generation, activity assessment and sequence prioritization.
IN DEVELOPMENT